Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ULTRA SHEER MOISTURIZING FACE SERUM SUNSCREEN - Health Canada Drug Approval Details

Approvals/Health Canada/ULTRA SHEER MOISTURIZING FACE SERUM SUNSCREEN

Authorized

STANDARD

ULTRA SHEER MOISTURIZING FACE SERUM SUNSCREEN

kenvue canada inc.🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: d60e0c4344c751fe
Company: kenvue canada inc.
Type: Standard

Approval Details

Approval Id: d60e0c4344c751fe
Drug Approval Canada Name: ULTRA SHEER MOISTURIZING FACE SERUM SUNSCREEN
Product Name: ULTRA SHEER MOISTURIZING FACE SERUM SUNSCREEN
Status: Marketed
Status Date: 2025-05-16
Original Market Date: 2022-01-17
Din: 02518384
Drug Class: Human
Dosage Form: Lotion
Route Of Administration: Topical
Schedule: OTC
Ahfs: 84:80.00
Atc Original: D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION
Atc Name: d 02 ba 30
Aig Number: 0451521090
Company Name: kenvue canada inc.
Company Address: 890 Woodlawn Road West, Guelph, Ontario, Canada, N1K 1A5

Active Ingredients

HOMOSALATE

13.5 % / W/W

AVOBENZONE

3 % / W/W

OCTISALATE

5 % / W/W

OCTOCRYLENE

10 % / W/W

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

d60e0c4344c751fe

Type

Standard

Back to Health Canada Approvals